Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Clinical trial NCT05029609 · WITHDRAWN

Trial details

NCT number: NCT05029609
Sponsor: Tiziana Life Sciences LTD
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis Multiple Sclerosis

Start date: 2021-10-01
Primary completion: 2022-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.